Hirofumi Ota

Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer

Ryoji Nonaka, Junichi Nishimura, Yoshinori Kagawa et al. · Oncology Reports · 2014 · 52 citations · Full text

Quantile regression approach to conditional mode estimation

Hirofumi Ota, Kengo Kato, Satoshi Hara · Electronic Journal of Statistics · 2019 · 43 citations · Full text

Safety and efficacy of an “enhanced recovery after surgery” protocol for patients undergoing colon cancer surgery: a multi-institutional controlled study

Hirofumi Ota, Masakazu Ikenaga, Junichi Hasegawa et al. · Surgery Today · 2016 · 42 citations

Enhanced Recovery, Surgical Oncology, Medicine +11

Terminal Complement Components Mediate Release of von Willebrand Factor and Adhesion of Platelets in Arteries of Allografts

Hirofumi Ota, Karen Fox-Talbot, Weimin Hu et al. · Transplantation · 2005 · 35 citations

Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea

Hiroyoshi Takemoto, Junichi Nishimura, Takamichi Komori et al. · International Journal of Clinical Oncology · 2016 · 35 citations

Oncology, Combination Antiemetic Therapy, Gastrointestinal Oncology +8